Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

Mandalà, Mario; Ferrari, Andrea; B. Brecht, Ines; P.M. Suijkerbuijk, Karijn; Maschke, Linda; Giannarelli, Diana; Indini, Alice; Ubaldi, Martina; Pecci, G; Atkinson, Victoria; Helgadóttir, Hildur; Chiaravalli, Stefano; Benannoune, Naima; Robert, Caroline; Teterycz, Paweł; Rutkowski, Piotr; Puig, Susana; Madonna, Gabriele; Kebudi, Rejin; Grynberg, Shirly; MRB Arantes, Lidia; Bień, Ewa; Krawczyk, Małgorzata; Debora De Pasquale, Maria; P. Dierselhuis, Miranda; Massi, Daniela; V. Long, Georgina; A. Ascierto, Paolo; M.M. Eggermont, Alexander

doi:10.1016/j.ejca.2024.114305

Public

Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

Published in European Journal of Cancer • Sep 3, 2024

Authors:

Mario Mandalà

Andrea Ferrari

Ines B. Brecht

Abstract

BACKGROUND: Data on the efficacy and safety of anti PD-1 antibodies in children and adolescents (CA) with melanoma are lacking. The aim of this study was to determine outcomes of CA melanoma patients receiving anti PD-1 antibodies. METHODS: Melanoma patients ≤18 years treated with anti PD-1 were ret...

Subject

Melanoma

Medicine

Antibody

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!